FEDERTI, Enrica
 Distribuzione geografica
Continente #
NA - Nord America 2.009
EU - Europa 1.682
AS - Asia 1.494
SA - Sud America 223
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 50
OC - Oceania 5
Totale 5.539
Nazione #
US - Stati Uniti d'America 1.919
RU - Federazione Russa 806
SG - Singapore 554
CN - Cina 327
IT - Italia 208
GB - Regno Unito 190
BR - Brasile 176
VN - Vietnam 176
HK - Hong Kong 172
DE - Germania 95
SE - Svezia 84
FR - Francia 78
IE - Irlanda 72
BD - Bangladesh 51
CA - Canada 51
FI - Finlandia 46
KR - Corea 42
JP - Giappone 33
ID - Indonesia 27
IN - India 27
AT - Austria 20
AR - Argentina 19
UA - Ucraina 16
MX - Messico 14
NL - Olanda 14
TR - Turchia 11
NG - Nigeria 10
TW - Taiwan 10
ES - Italia 9
PL - Polonia 9
CO - Colombia 8
EG - Egitto 8
IQ - Iraq 8
LT - Lituania 8
MY - Malesia 8
PK - Pakistan 8
TG - Togo 7
ZA - Sudafrica 7
BE - Belgio 6
BJ - Benin 6
CL - Cile 6
CW - ???statistics.table.value.countryCode.CW??? 6
EC - Ecuador 6
PH - Filippine 6
IR - Iran 5
MA - Marocco 5
AU - Australia 4
CR - Costa Rica 4
GT - Guatemala 4
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
VE - Venezuela 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
NI - Nicaragua 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
OM - Oman 2
PY - Paraguay 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BT - Bhutan 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
ST - Sao Tome e Principe 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 5.470
Città #
Ashburn 325
Moscow 311
Singapore 286
San Jose 212
Hong Kong 169
Chandler 157
Dallas 144
Southend 134
Dublin 72
Verona 65
Beijing 63
Council Bluffs 61
Jacksonville 46
Ho Chi Minh City 44
The Dalles 42
New York 35
Los Angeles 34
Ann Arbor 33
Wilmington 32
Tokyo 31
Dong Ket 30
Hanoi 28
Houston 27
Munich 27
Jakarta 24
Helsinki 23
Lawrence 23
Princeton 22
Milan 21
Santa Clara 19
Seattle 17
Redondo Beach 16
São Paulo 16
Jinan 14
Rome 14
Buffalo 13
Nanjing 13
Sindelfingen 13
Vienna 13
London 12
Atlanta 11
Blacksburg 11
Hebei 11
Montreal 11
Nuremberg 11
Redmond 11
Columbus 10
Frankfurt am Main 10
Guangzhou 10
Orem 10
Turku 10
Collegeville 9
Falls Church 9
Warsaw 9
West Lafayette 9
Bologna 8
Campinas 8
Chicago 8
Tianjin 8
Zhengzhou 8
Abuja 7
Belo Horizonte 7
Boardman 7
Brooklyn 7
Denver 7
Haiphong 7
Lappeenranta 7
Lomé 7
Nanchang 7
San Francisco 7
Toronto 7
Washington 7
Woodbridge 7
Chennai 6
City of London 6
Cotonou 6
Da Nang 6
Hangzhou 6
McKinney 6
Ningbo 6
Shanghai 6
Shenyang 6
Willemstad 6
Baghdad 5
Brasília 5
Brussels 5
Cambridge 5
Changsha 5
Cincinnati 5
Detroit 5
Dongguan 5
Memphis 5
Perryville 5
Tacoma 5
Xi'an 5
Amman 4
Amsterdam 4
Boston 4
Cagliari 4
Chieti 4
Totale 3.104
Nome #
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 287
Peroxiredoxin 2 Plays a Pivotal Role Against Oxidation in the Early Phase of Pulmonary Artery Hypertension 267
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 252
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 224
New Therapeutic Options for the Treatment of Sickle Cell Disease. 202
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 195
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 193
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 182
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 179
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 178
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 172
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model 165
Dietary ω-3 fatty acid supplementation improves murine sickle cell bone disease and reprograms adipogenesis 159
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 155
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 154
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 150
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 150
17(R)-Resolvin d1 protects against sickle cell- related inflammatory cardiomyopathy in humanized mice 148
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 147
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 146
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease 145
Duality of Nrf2 in iron-overload cardiomyopathy 145
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 145
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 142
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 142
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 139
Nrf2 Plays a Key Role in Erythropoiesis during Aging 129
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease 120
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 119
In humanized sickle cell mice, imatinib protects against sickle cell-related injury 115
Erythrocyte pyruvate kinase activation in red cell disorders. 111
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 98
Targeting lyn kinase in chorea-acanthocytosis: A translational treatment approach in a rare disease 98
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 95
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease 75
Exercise reveals precocious-subclinical cardiovascular and muscular dysfunction in transfusion dependent beta-thalassemia (TDT) patients without cardiac iron overload 16
Totale 5.539
Categoria #
all - tutte 18.384
article - articoli 15.468
book - libri 0
conference - conferenze 2.324
curatela - curatele 0
other - altro 592
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 0 0 14 6 9 12 18 4 10 43
2022/2023495 26 71 43 67 31 118 0 18 41 51 18 11
2023/2024411 12 21 30 49 41 42 19 27 3 22 117 28
2024/2025915 49 40 42 143 41 64 69 43 143 62 75 144
2025/20262.529 166 100 159 380 701 159 230 136 207 159 87 45
2026/2027442 66 50 80 242 4 0 0 0 0 0 0 0
Totale 5.539